ZTS
HEALTHCAREZoetis Inc - Class A
$111.22-1.32 (-1.17%)PRE
Live · NYSE · May 8, Close
AI Insight
What's Moving ZTS Today?
No stock-specific AI insight has been generated for ZTS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$85.32$169.60
$111.22
Fundamentals
Market Cap$46.9B
P/E Ratio18.5
EPS$6.02
Dividend Yield0.02%
Dividend / Share$2.00
ROE0.7%
Profit Margin0.3%
Debt / Equity—
Trading
Volume5.3M
Avg Volume (10D)—
Shares Outstanding420.5M
ZTS News
23 articles- Sector Update: Healthcare Stocks Lower Late AfternoonYahoo Finance·May 8, 2026
- Here’s Why IDEXX Laboratories Stock Could Deliver Around 11% Annual Returns Despite a 15% YTD PullbackTIKR.com·May 8, 2026
- Company News for May 8, 2026Yahoo Finance·May 8, 2026
- Zoetis (ZTS) Is Down 24.1% After Cutting 2026 Guidance On Softer U.S. Pet Demand – Has The Bull Case Changed?Yahoo Finance·May 8, 2026
- Zoetis Inc. Q1 2026 Earnings Call SummaryMoby·May 8, 2026
- US Equity Markets End Lower as Conflicting US Signals on Iran War Weigh on SentimentYahoo Finance·May 7, 2026
- Zoetis (ZTS) Q1 2026 Earnings TranscriptMotley Fool·May 7, 2026
- Why Zoetis' Slashed 2026 Guidance Still Appears To Be A 'Heavy Lift'Yahoo Finance·May 7, 2026
- Zoetis Is Today’s Worst S&P 500 Stock. Why the Quarter Is ‘Worse Than It Seems.’Yahoo Finance·May 7, 2026
- Why Zoetis Shares Plummeted TodayMotley Fool·May 7, 2026
- Qualcomm, Datadog among market cap stock movers on ThursdayInvesting.com·May 7, 2026
- Zoetis Q1 Earnings Lag Estimates, 2026 View Cut, Stock DownYahoo Finance·May 7, 2026
- Top Midday Stories: Citi CEO Fraser Gives New ROTCE Targets; Datadog Shares Soar After Strong Earnings, Bullish GuidanceYahoo Finance·May 7, 2026
- Zoetis (ZTS) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesYahoo Finance·May 7, 2026
- Zoetis (ZTS) Misses Q1 Earnings and Revenue EstimatesYahoo Finance·May 7, 2026
- Zoetis (NYSE:ZTS) Misses Q1 CY2026 Revenue Estimates, Stock Drops 13%Yahoo Finance·May 7, 2026
- Zoetis Announces First Quarter 2026 ResultsYahoo Finance·May 7, 2026
- Is Zoetis (ZTS) Offering Value After A 24% One Year Share Price Decline?Yahoo Finance·May 5, 2026
- These 4 Dividend Growers Have Already Declared 10% Dividend Increases247 Wall St·May 5, 2026
- Curious about Zoetis (ZTS) Q1 Performance? Explore Wall Street Estimates for Key MetricsYahoo Finance·May 5, 2026
- Five Dividend Growers Trading at Double-Digit Discounts Despite Strong Fundamentals247 Wall St·May 4, 2026
- Analysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out forYahoo Finance·May 4, 2026
- Worried About a Stock Market Crash? History Says Don't Sweat It.The Motley Fool·Mar 31, 2026
All 23 articles loaded
Price Data
Open$113.69
Previous Close$112.54
Day High$115.13
Day Low$110.94
52 Week High$169.60
52 Week Low$85.32
52-Week Range
$85.32$169.60
$111.22
Fundamentals
Market Cap$46.9B
P/E Ratio18.5
EPS$6.02
Dividend Yield0.02%
Dividend / Share$2.00
ROE0.7%
Profit Margin0.3%
Debt / Equity—
Trading
Volume5.3M
Avg Volume (10D)—
Shares Outstanding420.5M
About Zoetis Inc - Class A
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—